| Literature DB >> 32028980 |
Melanie T P Le1, Niloufar Zarinabad1, Tommaso D'Angelo1,2, Ibnul Mia1, Robert Heinke1, Thomas J Vogl3, Andreas Zeiher4, Eike Nagel1, Valentina O Puntmann5,6.
Abstract
BACKGROUND: Myocardial perfusion with cardiovascular magnetic resonance (CMR) imaging is an established diagnostic test for evaluation of myocardial ischaemia. For quantification purposes, the 16 segment American Heart Association (AHA) model poses limitations in terms of extracting relevant information on the extent/severity of ischaemia as perfusion deficits will not always fall within an individual segment, which reduces its diagnostic value, and makes an accurate assessment of outcome data or a result comparison across various studies difficult. We hypothesised that division of the myocardial segments into epi- and endocardial layers and a further circumferential subdivision, resulting in a total of 96 segments, would improve the accuracy of detecting myocardial hypoperfusion. Higher (sub-)subsegmental recording of perfusion abnormalities, which are defined relatively to the normal reference using the subsegment with the highest value, may improve the spatial encoding of myocardial blood flow, based on a single stress perfusion acquisition.Entities:
Keywords: 16 segment AHA model; Cardiovascular magnetic resonance; Myocardial perfusion; Myocardial segmentation; Sub-segmentation
Mesh:
Substances:
Year: 2020 PMID: 32028980 PMCID: PMC7006214 DOI: 10.1186/s12968-020-0600-1
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Imaging Protocol. Stress perfusion during adenosine infusion, followed by a cine imaging short axis stack and late gadolinium enhancement (LGE). The total dose of gadolinium based contrast agent (GBCA) is Gadovist® 0.1 mmol/kg body weight. Scan time for this protocol amounts to approximately 20 min
Fig. 2Cardiac segmentation. 16 segment model using the classic AHA model (top row and left), subdivision into 32 segments by epi- and endocardial division as well as (sub-)subdivision into 96 segments by dividing each subsegment into 3 further circumferential segments (lower row, only the mid-slice is shown for demonstration)
Subjects’ characteristics, medication and cardiovascular magnetic resonance (CMR) findings
| Variables | Controls | CAD patients ( | Significance |
|---|---|---|---|
| Age (years) | 49 ± 13 | 53 ± 12 | 0.27 |
| Males, n (%) | 12 (60) | 16 (53) | 0.631 |
| BMI, kg/m2 | 26 ± 3 | 28 ± 4 | 0.063 |
| Heart rate, bpm | 61 ± 12 | 60 ± 11 | 0.763 |
| BP systolic, mmHg | 115 ± 9 | 132 ± 11 | 0.304 |
| BP diastolic, mmHg | 72 ± 10 | 76 ± 11 | 0.198 |
| Hypertension, n (%) | 24 (80) | ||
| Diabetes mellitus (type 2), n (%) | 17 (57) | ||
| Hypercholesterolemia, n (%) | 28 (93) | ||
| Smoking, n (%) | 16 (53) | ||
| Angina CCS > II, n (%) | 18 (60) | ||
| Dyspnoea, n (%) | 12 (40) | ||
| History of PCI n (%) | 16 (53) | ||
| Cardiac medication | |||
| Aspirin, n (%) | 27 (90) | ||
| Anticoagulation, n (%) | 3 (10) | ||
| Betablockers, n (%) | 26 (87) | ||
| Calcium channel blockers, n (%) | 17 (57) | ||
| RAS-Inhibitors, n (%) | 26 (87) | ||
| Lipid-lowering therapy, n (%) | 27 (90) | ||
| Antianginals, n (%) | 16 (53) | ||
| Blood markers | |||
| Haematocrit (%) | 44 ± 4 | 42 ± 6 | 0.197 |
| eGFR, ml/min/1.73 m2 | 84 ± 5 | 69 ± 8 | < 0.001 |
| Hs-CRP, mg/l | 3.6 ± 2.8 | 4.8 ± 3.3 | 0.006 |
| Cath findings | |||
| Single vessel disease n (%) | 14 (47) | ||
| LAD | 6 | ||
| RCX | 3 | ||
| RCA | 6 | ||
| 3-vessel-disease or equivalent, n (%) | 6 (20) | ||
| CMR measures of function and structure | |||
| LV-EDV (index), ml/m2 | 78 ± 9 | 81 ± 8 | 0.223 |
| LV-ESV (index), ml/m2 | 32 ± 8 | 34 ± 7 | 0.355 |
| LV-EF, % | 61 ± 5 | 59 ± 6 | 0.224 |
| LV-mass (index), g/m2 | 58 ± 8 | 74 ± 7 | < 0.001 |
| RV-EF, % | 54 ± 6 | 56 ± 6 | 0.254 |
| Myocardial LGE, present, n (%) | / | 12 (40) | / |
BP Blood pressure, BMI Body mass index, CAD Coronary artery disease, RAS Renin angiotensin system, eGFR Estimated glomerular filtration rate, hs-CRP High sensitive C-reactive protein, LV Left ventricular, EDV End-diastolic volume, ESV End-systolic volume, EF Ejection fraction, LA Left atrium, LGE Late gadolinium enhancement, PCI Percutaneous coronary intervention, RCA Right coronary artery, LAD Left anterior descending coronary artery, LCX Left circumflex coronary artery, RV Right ventricle/ventricular
Fig. 3Results of receiver operator characteristics (ROC) curve analysis in identifying subjects with significant coronary artery disease (CAD). a: ROC curves for 16 segments (black), 32 segments (orange) and 96 segments (green); b: ROC curves for 16 segments (black), endo−/epicardial ratio based on 32 segments (orange) and endo−/epicardial ratio based on 96 segments (green)
Results of receiver operating characteristics curve analyses and comparisons
| Area under the curve (95% Confidence Interval) | Significance ( | Sensitivity | Specificity | Area under the curve comparisons | ||||
|---|---|---|---|---|---|---|---|---|
| Z | z | |||||||
| #16 | 0.820 (0.690–0.951) | < 0.001 | 0.93 | 0.63 | Vs. 16 | Vs. 32 | ||
| #32 | 0.937 (0.875–0.998) | < 0.001 | 0.90 | 0.84 | 2.15 | 0.032 | ||
| #48 | 0.973 (0.933–1.00) | < 0.001 | 0.97 | 0.90 | 1.96 | 0.015 | 1.38 | 0.167 |
| #96 | 0.993 (0.981–1.00) | < 0.001 | 0.93 | 1.00 | 2.67 | 0.008 | 2.02 | 0.044 |
| endo−/epicadial#16 | 0.932 (0.862–1.00) | < 0.001 | 0.87 | 0.95 | 1.70 | 0.89 | ||
| endo−/epicardial#48 | 0.979 (0.952–1.00) | < 0.001 | 0.87 | 1.00 | 2.57 | 0.015 | 1.82 | 0.069 |
Fig. 4Scatterplots demonstrating percent ischaemia in controls vs. CAD patients. For controls, single vessel disease (1-VD), dual vessel disease (2-VD) and triple vessel disease (3-VD) for the classic 16 segment analysis (a), 32 subsegment analysis (b) 48 subsegment analysis (c) 96 subsegment analysis (d), endo−/epicardial ratio based on 32 segments (Endo-Epi ratio #16) (e) as well as endo-epicardial ratio based on 96 segments (Endo-Epi ratio #48) (f)